BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,070 filers reported holding BAXTER INTL INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,981,785 | -25.3% | 79,009 | -9.8% | 0.00% | -20.0% |
| Q2 2023 | $3,991,915 | +2.6% | 87,619 | -8.7% | 0.01% | -16.7% |
| Q1 2023 | $3,891,863 | +11.8% | 95,953 | +40.5% | 0.01% | +20.0% |
| Q4 2022 | $3,480,643 | -5.0% | 68,288 | +0.4% | 0.01% | -16.7% |
| Q3 2022 | $3,662,000 | -11.7% | 67,983 | +5.2% | 0.01% | -14.3% |
| Q2 2022 | $4,149,000 | -19.0% | 64,597 | -2.2% | 0.01% | -12.5% |
| Q1 2022 | $5,121,000 | -6.9% | 66,043 | +3.1% | 0.01% | -11.1% |
| Q4 2021 | $5,500,000 | +8.0% | 64,070 | +1.2% | 0.01% | 0.0% |
| Q3 2021 | $5,091,000 | -3.6% | 63,302 | -3.5% | 0.01% | 0.0% |
| Q2 2021 | $5,281,000 | -4.6% | 65,605 | -0.0% | 0.01% | -18.2% |
| Q1 2021 | $5,535,000 | +3.0% | 65,628 | -2.1% | 0.01% | -8.3% |
| Q4 2020 | $5,376,000 | +3.4% | 67,005 | +3.7% | 0.01% | -14.3% |
| Q3 2020 | $5,197,000 | +5.1% | 64,627 | +12.5% | 0.01% | 0.0% |
| Q2 2020 | $4,946,000 | +9.6% | 57,440 | +3.3% | 0.01% | -12.5% |
| Q1 2020 | $4,513,000 | -1.2% | 55,589 | +1.7% | 0.02% | +14.3% |
| Q4 2019 | $4,569,000 | +1.0% | 54,644 | +5.6% | 0.01% | -6.7% |
| Q3 2019 | $4,524,000 | -37.3% | 51,722 | -41.4% | 0.02% | -37.5% |
| Q2 2019 | $7,216,000 | +76.6% | 88,307 | +75.7% | 0.02% | +60.0% |
| Q1 2019 | $4,086,000 | +16.8% | 50,252 | -5.5% | 0.02% | +7.1% |
| Q4 2018 | $3,498,000 | -12.1% | 53,150 | +3.0% | 0.01% | -6.7% |
| Q3 2018 | $3,978,000 | +11.6% | 51,604 | +6.9% | 0.02% | +7.1% |
| Q2 2018 | $3,566,000 | +20.0% | 48,290 | +5.7% | 0.01% | +16.7% |
| Q1 2018 | $2,972,000 | +10.9% | 45,697 | +10.2% | 0.01% | 0.0% |
| Q4 2017 | $2,680,000 | +9.8% | 41,464 | +6.6% | 0.01% | +9.1% |
| Q3 2017 | $2,441,000 | +8.2% | 38,907 | +4.4% | 0.01% | 0.0% |
| Q2 2017 | $2,256,000 | +28.2% | 37,260 | +9.8% | 0.01% | +10.0% |
| Q1 2017 | $1,760,000 | +6.5% | 33,935 | -8.9% | 0.01% | 0.0% |
| Q4 2016 | $1,652,000 | +6.6% | 37,254 | +14.4% | 0.01% | 0.0% |
| Q3 2016 | $1,550,000 | +19.2% | 32,553 | +13.2% | 0.01% | +11.1% |
| Q2 2016 | $1,300,000 | -10.7% | 28,755 | -18.8% | 0.01% | -18.2% |
| Q1 2016 | $1,455,000 | +19.3% | 35,418 | +10.7% | 0.01% | +10.0% |
| Q4 2015 | $1,220,000 | +18.6% | 31,981 | +2.1% | 0.01% | +11.1% |
| Q3 2015 | $1,029,000 | -55.7% | 31,310 | -5.7% | 0.01% | -57.1% |
| Q2 2015 | $2,322,000 | +1.5% | 33,210 | -0.6% | 0.02% | -4.5% |
| Q1 2015 | $2,288,000 | +5.8% | 33,395 | +13.1% | 0.02% | 0.0% |
| Q4 2014 | $2,163,000 | +2.9% | 29,514 | +0.8% | 0.02% | -8.3% |
| Q3 2014 | $2,102,000 | +11.1% | 29,285 | +11.9% | 0.02% | -4.0% |
| Q2 2014 | $1,892,000 | +6.1% | 26,173 | +8.0% | 0.02% | -7.4% |
| Q1 2014 | $1,783,000 | +12.8% | 24,238 | +6.7% | 0.03% | 0.0% |
| Q4 2013 | $1,580,000 | +14.8% | 22,722 | +8.5% | 0.03% | 0.0% |
| Q3 2013 | $1,376,000 | +7.5% | 20,948 | +13.3% | 0.03% | -10.0% |
| Q2 2013 | $1,280,000 | – | 18,481 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |